Investigation Report on China Deproteinized Calf Blood Extract Market [2010-2019]
- Submitted by: SarahDavis12
- Views: 91
- Category: Other
- Date Submitted: 12/20/2015 10:03 PM
- Pages: 3
- Report this Essay
Dec., 21, 2015, Mumbai, India: Market Reports on China presents the report, on “Investigation Report on China Deproteinized Calf Blood Extract Market [2010-2019]”. According to market survey, the sales value of deproteinized calf blood extract in sample hospitals reached about CNY 1.2 billion and CAGR during the period of 2005-2014 surpassed 30%.
As a drug improving energy metabolism, deproteinized calf blood extract has received wide attention due to its efficacy in nervous system. "http://www.marketreportsonchina.com/life-sciences-market-research-reports-17711/investigation-china-deproteinized-calf-blood-extract.html" Currently, it is mainly used to treat brain disease, nervous system disease, vascular disease, ulcer, burn, radiation injury and eye disease.
Developed by Jaeger KH with membrane filtering technology, deproteinized calf blood extract is the deproteinized blood extract of new-born calf with a relative molecular mass of less than 6000 dalton. Since the 1960s, deproteinized calf blood extract has been marketed all over the world.
Recently, nervous system drug has reported a stable growth. Among the TOP500 drugs in the seven big markets, nervous system drug reported a sales value of USD 43.286 billion with a year-on-year growth of 3% in 2013. Brain system drug, in particular, has undergone a downturn in global market. However, as people become increasingly aware of the pathogenesis and clinical pharmacology of neurologic diseases, the market of neurologic drug has grown fast in China. As a leading neurologic drug, deproteinized calf blood extract has reported a large sales in China. By the end of Aug.2015, there are 18 manufacturers of deproteinized calf blood extract and deproteinized calf blood extract injection, 3 manufactures of deproteinized calf blood extract ophthalmic gel and 1 manufacturer of deproteinized calf blood extract capsule.
According to market survey, the sales value of deproteinized calf blood extract in sample hospitals...
As a drug improving energy metabolism, deproteinized calf blood extract has received wide attention due to its efficacy in nervous system. "http://www.marketreportsonchina.com/life-sciences-market-research-reports-17711/investigation-china-deproteinized-calf-blood-extract.html" Currently, it is mainly used to treat brain disease, nervous system disease, vascular disease, ulcer, burn, radiation injury and eye disease.
Developed by Jaeger KH with membrane filtering technology, deproteinized calf blood extract is the deproteinized blood extract of new-born calf with a relative molecular mass of less than 6000 dalton. Since the 1960s, deproteinized calf blood extract has been marketed all over the world.
Recently, nervous system drug has reported a stable growth. Among the TOP500 drugs in the seven big markets, nervous system drug reported a sales value of USD 43.286 billion with a year-on-year growth of 3% in 2013. Brain system drug, in particular, has undergone a downturn in global market. However, as people become increasingly aware of the pathogenesis and clinical pharmacology of neurologic diseases, the market of neurologic drug has grown fast in China. As a leading neurologic drug, deproteinized calf blood extract has reported a large sales in China. By the end of Aug.2015, there are 18 manufacturers of deproteinized calf blood extract and deproteinized calf blood extract injection, 3 manufactures of deproteinized calf blood extract ophthalmic gel and 1 manufacturer of deproteinized calf blood extract capsule.
According to market survey, the sales value of deproteinized calf blood extract in sample hospitals...